查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1631481

冠状动脉支架市场规模、份额、趋势分析报告：按产品、最终用途、地区、细分市场预测，2025-2030 年

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents (BMS), Drug Eluting Stents (DES), Bioresorbable Vascular Scaffold), By End Use (Inpatient and Outpatient Facilities), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

冠状动脉支架市场的成长与趋势

根据 Grand View Research, Inc. 的一份新报告，到 2030 年全球冠状动脉支架市场规模预计将达到 97 亿美元。预计 2025 年至 2030 年间市场复合年增长率将达到 2.6%。预计未来几年微创手术和经皮冠状动脉介入治疗 (PCI) 程序的普及将推动市场的发展。例如，根据《韩国胸腔心臟血管外科杂誌》的报告，2016年冠状动脉疾病（CAD）的PCI率为78%，全国PCI率为96%，均明显高于全球平均。因此，随着 CAD 盛行率的不断上升，预计在这些 CAD 患者中实施 PCI 的比例将会增加，从而推动对有效冠状动脉支架技术的需求。

技术进步和第二代药物释放型支架的推出进一步推动了成长。例如，雅培实验室的 XIENCE Sierra 于 2018 年 5 月成为美国首个核准用于 CTO 的 DES。美敦力公司于 2019 年初效仿，获得 FDA核准其 Resolute 系列 DES 用于治疗 CTO 适应症。此外，近期多家公司在美国推出了其冠状动脉支架系统的新型版本，尤其是波士顿科学公司于 2021 年 1 月推出的 Synergy Megatron 和雅培实验室于 2021 年 6 月推出的 XIENCE Skypoint。

COVID-19 疫情对冠状动脉支架市场产生了不利影响。根据世界各地医学协会的指导方针，手术延迟主要影响合格患者的非紧急和选择性手术。例如，美国心臟学会（ACC）2020年指引建议在COVID-19疫情高峰期间延后非紧急程序，例如CTO介入和监测血管造影术。这些指南影响着世界各地医生的治疗决策。此外，根据欧洲心臟病学会的建议，在疫情尖峰时段，应继续进行所有紧急和急诊 PCI 手术（治疗 STEMI、高风险或中危 NSTEMI、心源性休克和不稳定型心绞痛），而只有选择性 PCI 手术（CTO 干预或治疗 NYHA II 症状）应推迟。

此外，预计紧急 PCI 手术的持续实施和非选择性手术的运转率提高将有助于冠状动脉支架市场从 COVID-19 大流行中復苏。

冠状动脉支架市场由公共医疗保险和医疗补助服务中心 (CMS) 和私人付款人提供的报销推动。颈动脉支架置入术的保险覆盖范围是根据包括产品和服务供应商在内的全国范围的覆盖范围决定的。从 2020 年 1 月开始，医疗保险和医疗补助服务中心 (CMS) 已提案对在门诊手术中心 (ASC) 进行的部分血管成形术和支架置入术进行报销，预计这将在预测期内增加市场收益。

冠状动脉支架市场报告重点

  • 由于新技术和治疗严重病变能力的提高，以及人口老化和合格PCI 治疗的患者数量的增加，采用冠状动脉支架装置治疗的 PCI 手术的总量将会增加。
  • 生物可吸收血管支架有望成为冠状动脉疾病治疗中成长第二快的领域，因为它具有多种优势，例如可以暂时放置在患者心臟内，三年内降解从而有利于未来的治疗，并且可以在患者体内完全溶解。
  • 良好的临床试验已经证明了 DES 相对于标准 BMS 的优越性。因此，DES 将在 2021 年占据市场主导地位。
  • 北美将主导冠状动脉支架市场，占据 2024 年 43.6% 的最大收益占有率。
  • 预计亚太地区冠状动脉支架市场将出现最快的产生收入。市场受到其他变数的推动，例如 CAD筛检的增加、经济成长、监管更新以及澳大利亚和韩国等一些国家明显优惠的报销政策。

目录

第一章调查方法与范围

第 2 章执行摘要

3. 冠状动脉支架市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 冠状动脉支架市场分析工具
    • 产业分析 – 波特五力分析
    • PESTEL 分析

第 4 章 冠状动脉支架市场：按产品分類的估计和趋势分析

  • 全球冠状动脉支架市场：产品仪表板
  • 全球冠状动脉支架市场：产品差异分析
  • 产品收益
  • 裸金属支架
  • 药物释放型支架
  • 生物可吸收血管支架 (BVS)/生物可吸收冠状动脉支架

5. 冠状动脉支架市场：依最终用途的估计和趋势分析

  • 全球冠状动脉支架市场：最终用途仪表板
  • 全球冠状动脉支架市场：最终用途差异分析
  • 按最终用途分類的收益
  • 住院设施
  • 门诊设施

6. 冠状动脉支架市场：按地区、产品和最终用途的估计和趋势分析

  • 区域控制面板
  • 2018-2030 年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 公司/竞争对手分类
  • 供应商概况
    • 2024 年主要企业的市场占有率分析
    • Abbott
    • Medtronic
    • Boston Scientific Corporation
    • Terumo Corporation
    • B Braun SE
    • BIoTronik.
    • Stentys SA
    • MicroPort Scientific Corporation
    • CR Bard, Inc.
    • Cook Medical
Product Code: GVR-1-68038-106-1

Coronary Stents Market Growth & Trends:

The global coronary stents market size is expected to reach USD 9.7 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.6% from 2025 to 2030. Increasing adoption of minimally invasive surgeries and Percutaneous Coronary Intervention (PCI) procedures is expected to drive the market in the coming years. For instance, according to The Korean Journal of Thoracic and Cardiovascular Surgery, the proportion of PCI for Coronary Artery Disease (CAD) was 78% in 2016, and the country-specific PCI proportion was 96%, which was significantly higher than the global average. As a result, the unprecedented growth in CAD incidence, along with an increase in the proportion of PCIs done in these CAD patients, is expected to raise demand for an effective coronary stent technology.

Technological advancement and the launch of 2nd generation drug-eluting stents are further fueling the growth. For instance, Abbott Laboratories Laboratories' XIENCE Sierra became the first DES approved for CTO indications in the US in May 2018. Medtronic followed suit in early 2019, obtaining FDA approval for the use of its Resolute range of DES in CTO indications. In addition, many companies have recently launched newer versions of their coronary stent systems in the US, notably Boston Scientific's Synergy Megatron in January 2021 and Abbott Laboratories Laboratories' XIENCE Skypoint in June 2021.

The global COVID-19 pandemic has had a negative impact on the market for coronary stents. According to guidelines from physician societies throughout the world, procedure deferrals primarily impacted less urgent or elective procedures for eligible patients. ACC's ((American College of Cardiology) 2020 guidance, for instance, recommended postponing non-urgent procedures like CTO interventions and surveillance angiography during the peak of the COVID-19 pandemic. These guidelines have influenced physicians' treatment decisions throughout the world. Additionally, according to the European Society of Cardiology recommendations, all emergency and urgent PCI procedures (treatment of STEMI, high or intermediate risk NSTEMI, cardiogenic shock, and unstable angina) should be continued during the peak of the pandemic and in the subsequent resurgence of COVID-19, while only elective PCI procedures (CTO interventions or treatment of NYHA II symptoms) should be deferred.

Moreover, recovery of the coronary stent market from the COVID-19 pandemic is anticipated to be aided by the continuous performance of urgent PCI procedures and an increase in capacity utilization for performing non-elective procedures.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare & Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service providers. From January 2020, the Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in the ambulatory surgical centers (ASC), which is expected to boost the market revenue over the forecast period.

Coronary Stents Market Report Highlights:

  • Overall PCI procedure volumes treated with coronary stent devices will rise as the aging population and the PCI-eligible patient population grows, owing to new technologies and increased ability to treat severe lesions
  • The bioresorbable vascular scaffold segment is expected to be the second fastest growing segment due to its several advantages in treating coronary artery disease including temporary placement in the patient heart, ease for future treatments as it degrades over 3 years, and it dissolve completely in the patient body.
  • Favorable clinical trials have demonstrated that DES is better than standard BMS. As a result, in 2021, DES has dominated the market
  • North America dominated the coronary stents market and accounted for the largest revenue share of 43.6% in 2024 and is anticipated to witness the same trend over the foreseeable future.
  • The Asia Pacific market for coronary stents is expected to exhibit the fastest growth rate in terms of revenue generation. This market is driven by some additional variables of enhanced screening for CAD, economic growth, regulatory updates, and notable beneficial reimbursement in some countries such as Australia and South Korea.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End Use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Coronary Stents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of cardiovascular diseases
      • 3.2.1.2. Technological advancements in stent designs
      • 3.2.1.3. Increasing healthcare access and awareness
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of advanced stents
      • 3.2.2.2. Risk of complications and side effects
  • 3.3. Coronary Stents Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Coronary Stents Market: Product Estimates & Trend Analysis

  • 4.1. Global Coronary Stents Market: Product Dashboard
  • 4.2. Global Coronary Stents Market: Product Movement Analysis
  • 4.3. Global Coronary Stents Market by Product, Revenue
  • 4.4. Bare Metal Stents
    • 4.4.1. Bare metal stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Drug Eluting Stents
    • 4.5.1. Drug eluting stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Bioresorbable Vascular Scaffolds (BVS)/Bioresorbable Coronary Stents
    • 4.6.1. Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Coronary Stents Market: End Use Estimates & Trend Analysis

  • 5.1. Global Coronary Stents Market: End Use Dashboard
  • 5.2. Global Coronary Stents Market: End Use Movement Analysis
  • 5.3. Global Coronary Stents Market Estimates and Forecasts, by End Use, Revenue (USD Million)
  • 5.4. Inpatient Facilities
    • 5.4.1. Inpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Outpatient Facilities
    • 5.5.1. Outpatient facilities market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Coronary Stents Market: Regional Estimates & Trend Analysis by Product and End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. Japan coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. China
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. China coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. Brazil coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Argentina
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Argentina coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. South Africa
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. South Africa coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.2. Saudi Arabia
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. Saudi Arabia coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. UAE coronary stents market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Kuwait coronary stents market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company/Competition Categorization
  • 7.2. Vendor Landscape
    • 7.2.1. Key company market share analysis, 2024
    • 7.2.2. Abbott
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Medtronic
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. Boston Scientific Corporation
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Terumo Corporation
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. B Braun SE
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Biotronik.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Stentys SA
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. MicroPort Scientific Corporation
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. C.R. Bard, Inc.
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
    • 7.2.11. Cook Medical
      • 7.2.11.1. Company overview
      • 7.2.11.2. Financial performance
      • 7.2.11.3. Product benchmarking
      • 7.2.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 5 U.S. coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 6 U.S. coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 7 Canada coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 8 Canada coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Mexico coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 10 Mexico coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 11 Europe coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 12 Europe coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Germany coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Germany coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 17 France coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 18 France coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 19 Italy coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 20 Italy coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Spain coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Spain coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Denmark coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Denmark coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Sweden coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 26 Sweden coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Norway coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Norway coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 30 Asia Pacific coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 32 China coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 33 China coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Japan coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 35 Japan coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 36 India coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 37 India coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 38 South Korea coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 39 South Korea coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 42 Thailand coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 43 Thailand coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Latin America coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 45 Latin America coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 46 Latin America coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 47 Brazil coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 48 Brazil coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Argentina coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 50 Argentina coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 51 MEA coronary stents market, by region, 2018 - 2030 (USD Million)
  • Table 52 MEA coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 53 MEA coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 54 South Africa coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 55 South Africa coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 58 UAE coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 59 UAE coronary stents market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Kuwait coronary stents market, by product, 2018 - 2030 (USD Million)
  • Table 61 Kuwait coronary stents market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 Coronary stents market: market outlook
  • Fig. 7 Coronary stents competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 Coronary stents market driver impact
  • Fig. 11 Coronary stents market restraint impact
  • Fig. 12 Coronary stents market: Product movement analysis
  • Fig. 13 Coronary stents market: Product outlook and key takeaways
  • Fig. 14 Bare metal stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Drug eluting stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Bioresorbable vascular scaffolds (BVS)/bioresorbable coronary stents coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Coronary stents market: End Use movement analysis
  • Fig. 18 Coronary stents market: End Use outlook and key takeaways
  • Fig. 19 Inpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Outpatient facilities coronary stents market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Global coronary stents market: Regional movement analysis
  • Fig. 22 Global coronary stents market: Regional outlook and key takeaways
  • Fig. 23 Global coronary stents market share and leading players
  • Fig. 24 North America, by country
  • Fig. 25 North America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 U.S. key country dynamics
  • Fig. 27 U.S. coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Canada key country dynamics
  • Fig. 29 Canada coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Mexico key country dynamics
  • Fig. 31 Mexico coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Europe coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 UK key country dynamics
  • Fig. 34 UK coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany key country dynamics
  • Fig. 36 Germany coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France key country dynamics
  • Fig. 38 France coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Italy key country dynamics
  • Fig. 40 Italy coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Spain key country dynamics
  • Fig. 42 Spain coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Denmark key country dynamics
  • Fig. 44 Denmark coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Sweden key country dynamics
  • Fig. 46 Sweden coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Norway key country dynamics
  • Fig. 48 Norway coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Asia Pacific coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 China key country dynamics
  • Fig. 51 China coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Japan key country dynamics
  • Fig. 53 Japan coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 India key country dynamics
  • Fig. 55 India coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand key country dynamics
  • Fig. 57 Thailand coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea key country dynamics
  • Fig. 59 South Korea coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Australia key country dynamics
  • Fig. 61 Australia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil key country dynamics
  • Fig. 64 Brazil coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina key country dynamics
  • Fig. 66 Argentina coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Middle East and Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa key country dynamics
  • Fig. 69 South Africa coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Saudi Arabia key country dynamics
  • Fig. 71 Saudi Arabia coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 UAE key country dynamics
  • Fig. 73 UAE coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait key country dynamics
  • Fig. 75 Kuwait coronary stents market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 76 Market share of key market players- Coronary stents market